Home - Products - Others - Other Targets - 9-hydroxy-4-androstene-317-dione

9-hydroxy-4-androstene-317-dione

CAS No. 560-62-3

9-hydroxy-4-androstene-317-dione( —— )

Catalog No. M21292 CAS No. 560-62-3

9-hydroxy-4-androstene-317-dione is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
25MG 32 In Stock
50MG 44 In Stock
100MG 63 In Stock
200MG 91 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    9-hydroxy-4-androstene-317-dione
  • Note
    Research use only, not for human use.
  • Brief Description
    9-hydroxy-4-androstene-317-dione is a chemical compound.
  • Description
    9-hydroxy-4-androstene-317-dione is a chemical compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    560-62-3
  • Formula Weight
    302.4
  • Molecular Formula
    C19H26O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1(O)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Anna Brzostek Jakub Pawelczyk Anna Rumijowska-Galewicz等. Mycobacterium tuberculosis Is Able To Accumulate and Utilize Cholesterol[J]. Journal of Bacteriology 2009 191(21):6584-6591.
molnova catalog
related products
  • Retro 2

    Retro 2 is a plant toxin ricin ?inhibitor, itprotects HeLa cells against Ricin, Stx1 and Stx2, selectively blocks retrograde toxin trafficking at the early endosome-TGN (trans-Golgi network) interface.

  • Maleuric acid

    Maleuric acid (N-Carbamoylmaleamic acid) is anti-mitotic and can be used in biological research in conjunction with radioautography.

  • hSMG-1 inhibitor 11e

    hSMG-1 inhibitor 11e is a potent and selective hSMG-1 kinase inhibitor with an IC50 of 900-fold selectivity over mTOR (IC50 of 45 nM), PI3Kα/γ (IC50s of 61 nM and 92 nM) and CDK1/CDK2 (IC50s of 32 μM and 7.1 μM).